First Do No Harm: Is It Safe to Use Immunosuppressants in Inflammatory Bowel Disease Patients With Prior Cancer?

被引：3
作者：
Nguyen, Geoffrey C. [1 ]
机构：
[1] Univ Toronto, Mt Sinai Hosp, Toronto, ON M5G 1X5, Canada
来源：
GASTROENTEROLOGY | 2016年 / 151卷 / 01期
关键词：
NONMELANOMA SKIN-CANCER; COMBINATION THERAPY; RISK; AZATHIOPRINE; EPIDEMIOLOGY; INFLIXIMAB; AGENTS;
D O I：
10.1053/j.gastro.2016.05.018
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：22 / 24
页数：4
相关论文
共 50 条
  • [31] Should Patients With Inflammatory Bowel Disease Take Vitamin D to Prevent Cancer?
    Bernstein, Charles N.
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2014, 12 (05) : 828 - 830
  • [32] Cancer in Inflammatory Bowel Disease
    Faye, Adam S.
    Holmer, Ariela K.
    Axelrad, Jordan E.
    GASTROENTEROLOGY CLINICS OF NORTH AMERICA, 2022, 51 (03) : 649 - 666
  • [33] Optimizing the use of biological therapy in patients with inflammatory bowel disease
    Moss, Alan C.
    GASTROENTEROLOGY REPORT, 2015, 3 (01): : 63 - 68
  • [34] Combination therapy in inflammatory bowel disease patients: do we need to maximize the dose of azathioprine?
    Arieira, Catia
    de Castro, Francisca Dias
    Goncalves, Tiago Curdia
    Moreira, Maria J.
    Cotter, Jose
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2020, 55 (08) : 920 - 923
  • [35] Mycophenolate mofetil is a valid option in patients with inflammatory bowel disease resistant to TNF-α inhibitors and conventional immunosuppressants
    Macaluso, Fabio Salvatore
    Maida, Marcello
    Renna, Sara
    Orlando, Emanuele
    Affronti, Marco
    Sapienza, Chiara
    Dimarco, Mariangela
    Orlando, Rosalba
    Rizzuto, Giulia
    Cottone, Mario
    Orlando, Ambrogio
    DIGESTIVE AND LIVER DISEASE, 2017, 49 (02) : 157 - 162
  • [36] Use of biologic agents in pediatric inflammatory bowel disease
    Rosh, Joel R.
    CURRENT OPINION IN PEDIATRICS, 2009, 21 (05) : 646 - 650
  • [37] Impaired Gastric Cancer Survival in Patients with Inflammatory Bowel Disease
    Nissen, Loes H. C.
    Assendorp, Eemke L.
    van der Post, Rachel S.
    Derikx, Lauranne A. A. P.
    de Jong, Dirk J.
    Kievit, Wietske
    Pierik, Marieke
    van den Heuvel, Tim
    Verhoeven, Rob
    Overbeek, Lucy I. H.
    Hoentjen, Frank
    Nagtegaal, Iris D.
    JOURNAL OF GASTROINTESTINAL AND LIVER DISEASES, 2016, 25 (04) : 431 - 440
  • [38] Safety and Efficacy of Bevacizumab in Cancer Patients with Inflammatory Bowel Disease
    Herrera-Gomez, Ruth Gabriela
    Grecea, Miruna
    Gallois, Claire
    Boige, Valerie
    Pautier, Patricia
    Pistilli, Barbara
    Planchard, David
    Malka, David
    Ducreux, Michel
    Mir, Olivier
    CANCERS, 2022, 14 (12)
  • [39] Which patients with inflammatory bowel disease should receive combination therapy?
    Cross, Raymond K.
    EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY, 2015, 9 (06) : 715 - 717
  • [40] Thiopurine Therapy in Patients With Inflammatory Bowel Disease: A Focus on Metabolism and Pharmacogenetics
    Chang, Ji Young
    Cheon, Jae Hee
    DIGESTIVE DISEASES AND SCIENCES, 2019, 64 (09) : 2395 - 2403
12345